These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12737129)

  • 1. Changing incidence of mycobacterial diseases in German patients with HIV infection.
    Mauss S; Wolf E; Hans J
    AIDS Read; 1999 Sep; 9(6):386, 391-2. PubMed ID: 12737129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Infection and non-tuberculous mycobacteria: how important in southern European countries?
    Valadas E; Hänscheid T; Antunes F
    Scand J Infect Dis; 2004; 36(9):685-6. PubMed ID: 15370656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontuberculous mycobacterial infections in King Chulalongkorn Memorial Hospital.
    Saritsiri S; Udomsantisook N; Suankratay C
    J Med Assoc Thai; 2006 Dec; 89(12):2035-46. PubMed ID: 17214054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial infections in patients with HIV: a review of disease and care.
    Hendell M
    Nurse Pract; 1998 Oct; 23(10):75-8, 83. PubMed ID: 9805333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Late AIDS diagnosis in patients hospitalized in Clinic of Infectious Diseases and Hepatology PAM in years 2003-2007].
    Bander D; Leszczyszyn-Pynka M; Boroń-Kaczmarska A
    Przegl Epidemiol; 2009; 63(1):61-6. PubMed ID: 19522228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, Kenya.
    Mwachari CW; Shepherd BE; Cleopa O; Odhiambo JA; Cohen CR
    Int J STD AIDS; 2004 Feb; 15(2):120-6. PubMed ID: 15006075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ and CD8+ lymphocytes and clinical features of HIV seropositive Nigerians on presentation.
    Onyemelukwe GC; Musa BO
    Afr J Med Med Sci; 2002 Sep; 31(3):229-33. PubMed ID: 12751562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
    de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
    Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Illnesses caused by ubiquitous mycobacteria. Clinical, therapeutic and microbiological aspects].
    Schütt-Gerowitt H
    Fortschr Med; 1996 Jul; 114(18-19):233-6. PubMed ID: 8766791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.
    Manfredi R; Nanetti A; Valentini R; Ferri M; Morelli S; Calza L
    HIV Med; 2004 Nov; 5(6):431-6. PubMed ID: 15544696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.